Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (SE:XVIVO)
:XVIVO
XVIVO Analyst Ratings
Hold
1 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
XVIVO Stock 12 Month Forecast
Average Price Target
kr392.49
▲(30.05%Upside)
| Highest Price Targetkr460.00 | Average Price Targetkr392.49 | Lowest Price Targetkr325.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
kr324
Hold
7.36%
Upside
Downgraded
06/13/25
Xvivo Perfusion AB has strong financial performance, with impressive revenue growth and a solid balance sheet. However, the high P/E ratio indicates potential overvaluation, and technical indicators suggest a lack of short-term momentum. The absence of a dividend yield further impacts its attractiveness. These factors contribute to a moderate overall stock score.
Danske Bank
kr560→kr325
Sell
7.69%
Upside
Downgraded
03/25/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
kr324
Hold
7.36%
Upside
Downgraded
06/13/25
Xvivo Perfusion AB has strong financial performance, with impressive revenue growth and a solid balance sheet. However, the high P/E ratio indicates potential overvaluation, and technical indicators suggest a lack of short-term momentum. The absence of a dividend yield further impacts its attractiveness. These factors contribute to a moderate overall stock score.
Danske Bank
kr560→kr325
Sell
7.69%
Upside
Downgraded
03/25/25
Best Analysts Covering Xvivo Perfusion AB
1 Month
xxx
Success Rate
1/1 ratings generated profit
Average Return
+6.40%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+0.50%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +0.50% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+0.50%
downgraded a sell rating 3 months ago
Copying Erik Cassel's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +0.50% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+0.50%
downgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +0.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XVIVO Analyst Recommendation Trends
Rating
Jun 23
Jul 24
Mar 25
Strong Buy
1
1
2
Buy
0
0
0
Hold
0
1
1
Sell
0
0
1
Strong Sell
0
0
0
total
1
2
4
Each month's total comprises the sum of three months' worth of ratings.
XVIVO Financial Forecast
XVIVO Stock Forecast FAQ
What is SE:XVIVO’s average 12-month price target, according to analysts?
Based on analyst ratings, Xvivo Perfusion AB’s 12-month average price target is 392.49.
What is SE:XVIVO’s upside potential, based on the analysts’ average price target?
Xvivo Perfusion AB has 30.05% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Xvivo Perfusion AB a Buy, Sell or Hold?
Xvivo Perfusion AB has a consensus rating of Hold, which is based on 1 buy ratings, 0 hold ratings and 1 sell ratings.
What is Xvivo Perfusion AB’s share price target?
The average share price target for Xvivo Perfusion AB is 392.49. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr460.00 ,and the lowest forecast is kr325.00. The average share price target represents 30.05% Increase from the current price of kr301.8.
The highest analyst share price target is kr460.00 ,and the lowest forecast is kr325.00. The average share price target represents 30.05% Increase from the current price of kr301.8.
What do analysts say about Xvivo Perfusion AB?
Xvivo Perfusion AB’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Xvivo Perfusion AB?
To buy shares of SE:XVIVO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.